Sep 2024 - Global pharmaceutical company Amneal Pharmaceuticals, Inc., and clinical-stage biopharmaceutical company Metsera, Inc., are accelerating next-generation medicines for obesity and metabolic diseases by joining forces with a portfolio of new weight loss medicines on efficient development and large-scale supply worldwide
If a patient stops the medication, diabetes will relapse (if it was controlled, not cured) and weight will likely be regained, as evidenced by trials where cessation led to weight regain trends
If you have noticed these symptoms, our medical team can help professionally determine whether your symptoms are caused by B12 deficiency and how B12 injections can benefit you
Book a virtual consultation to discuss your weight loss goals and medical history with our physician
G., Gratzl, S., Brar, R., Baker, C., Gluckman, T
Mar 8 2023;13(6):1037